Skip to content
The Kids Research Institute Australia logo
Donate

Discover . Prevent . Cure .

Novel drug targets for asthma and COPD: Lessons learned from in vitro and in vivo models

This paper is a review of potential novel therapeutic targets or tools for the treatment of asthma and COPD.

Authors:
Baker KE, Bonvini SJ, Donovan C, Foong RE, Han B, et al.

Authors notes:
Pulmonary Pharmacology and Therapeutics.

Keywords:
G-protein coupled receptor, inflammation, kinase, therapeutic targets, transient receptor potential channel, vitamin D

Abstract:
Asthma and chronic obstructive pulmonary disease (COPD) are highly prevalent respiratory diseases characterized by airway inflammation, airway obstruction and airway hyperresponsiveness.

Whilst current therapies, such as β-agonists and glucocorticoids, may be effective at reducing symptoms, they do not reduce disease progression.

Thus, there is a need to identify new therapeutic targets.

In this review, we summarize the potential of novel targets or tools, including anti-inflammatories, phosphodiesterase inhibitors, kinase inhibitors, transient receptor potential channels, vitamin D and protease inhibitors, for the treatment of asthma and COPD.